Page last updated: 2024-10-22

amiodarone and Asymmetric Septal Hypertrophy, Familial

amiodarone has been researched along with Asymmetric Septal Hypertrophy, Familial in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"We report a case of amiodarone-induced thyrotoxicosis, and a broad review of the literature."8.82[Amiodarone-induced thyrotoxicosis: case report and review of the literature]. ( Bianconcini, M; Giannini, AL, 2003)
"We report a case of amiodarone-induced thyrotoxicosis, and a broad review of the literature."4.82[Amiodarone-induced thyrotoxicosis: case report and review of the literature]. ( Bianconcini, M; Giannini, AL, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianconcini, M1
Giannini, AL1

Reviews

1 review available for amiodarone and Asymmetric Septal Hypertrophy, Familial

ArticleYear
[Amiodarone-induced thyrotoxicosis: case report and review of the literature].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:8

    Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Cardiomyopathy, Hypertrophic, Familia

2003